10.02.2005 22:15:00

ADVISORY/Quovadx Executive Provides Roadmap to Navigate the Clinical D

ADVISORY/Quovadx Executive Provides Roadmap to Navigate the Clinical Data Sharing Process


    Business Editors/Healthcare Writers
    ADVISORY...for Tuesday (Feb. 15)
    HIMSS 2005 Annual Conference

    --(BUSINESS WIRE)--

Dr. Ron Paulus Discusses Strategies for Traversing Technical, Political and Funding Hurdles in Establishing RHIOs at HIMSS 2005 Conference


Who: Ronald Paulus, M.D., M.B.A., chief healthcare officer, Quovadx, Inc.

Dr. Paulus is actively involved in developing technologies that facilitate clinical data sharing and care management and he belongs to several organizations that support the adoption of interoperable healthcare technology. He is a member of the Interoperability Workgroup for the Certification Commission for Healthcare Information Technology (CCHIT), a group formed by the American Health Information Management Association (AHIMA), Healthcare Information and Management Systems Society (HIMSS) and the National Alliance for Health Information Technology.

Dr. Paulus was a co-founder of CareScience, Inc. with David Brailer, M.D., Ph.D., where he served as president and chief executive officer prior to the Quovadx acquisition. Dr. Paulus has published numerous articles in the areas of clinical cost-effectiveness and clinical performance improvement, and the neurological structures used in memory. He has also lectured in the Wharton MBA program and speaks nationally on topics such as care management, clinical performance improvement, clinical data sharing, quality measurement, the application of information technology to improve health care services and physician leadership.

What: "The Value of Community-Wide Interoperability for Clinical Data Sharing" Having worked with clients on their clinical data exchange needs for many years, Dr. Paulus will outline, through real world examples, including the Santa Barbara Community Care Data Exchange(R) project, the steps regional communities can take to start to overcome the political, technical and funding hurdles needed to deliver on this important promise.

Dr. Paulus' presentation will precede a presentation by Mike Skinner, executive director of the Santa Barbara County Care Data Exchange project, who will offer a community perspective and more detailed insight into the development of interoperability standards that support RHIOs like the Santa Barbara County Care Data Exchange.

When: Tuesday, February 15, 2005 Dr. Ronald Paulus, Quovadx: 4:45 - 5:15PM Mike Skinner, Santa Barbara: 5:30 - 6:00PM

Where: Healthcare Information and Management Systems Society (HIMSS) Annual Conference IHE Interoperability Showcase Theater Dallas Convention Center Dallas, Texas

Contact: Abby Aylman Cohen (212) 850-5710/(917) 596-4758 acohen@fd-us.com



    Care Data Exchange is a registered trademark of the California Healthcare Foundation. QUOVADX is a trademark of Quovadx, Inc. All other company and product names mentioned may be trademarks of the companies with which they are associated.

--30--SL/dx*

CONTACT: Quovadx, Inc. Abby Aylman Cohen, 212-850-5710 or 917-596-4758 acohen@fd-us.com

KEYWORD: COLORADO TEXAS TRACK INDUSTRY KEYWORD: MEDICAL TRADESHOW ADVISORY SOURCE: Quovadx, Inc.

Copyright Business Wire 2005

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Quovadx Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Quovadx Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 20 041,20 0,00%